Endoplasmic reticulum stress and autophagy are involved in adipocyte-induced fibrosis in hepatic stellate cells
- PMID: 33638026
- DOI: 10.1007/s11010-020-03990-6
Endoplasmic reticulum stress and autophagy are involved in adipocyte-induced fibrosis in hepatic stellate cells
Abstract
Liver fibrosis, with the characterization of progressive accumulation of extracellular matrix (ECM), is the common pathologic feature in the process of chronic liver disease. Hepatic stellate cells (HSCs) which are activated and differentiate into proliferative and contractile myofibroblasts are recognized as the main drivers of fibrosis. Obesity-related adipocytokine dysregulation is known to accelerate liver fibrosis progression, but the direct fibrogenic effect of mature adipocytes on HSCs has been rarely reported. Therefore, the purpose of this study was to explore the fibrogenic effect of adipocyte 3T3-L1 cells on hepatic stellate LX-2 cells. The results showed that incubating LX-2 cells with the supernatant of 3T3-L1 adipocytes triggered the expression of ECM related proteins, such as α-smooth muscle actin (α-SMA), type I collagen (CO-I), and activated TGF β/Smad2/3 signaling pathway in LX-2 cells. In addition, 3T3-L1 cells inhibited insulin sensitivity, activated endoplasmic reticulum stress and autophagy to promote the development of fibrosis. These results supported the notion that mature adipocytes can directly activate hepatic stellate cells, and the establishment of an in vitro model of adipocytes on HSCs provides an insight into screening of drugs for liver diseases, such as nonalcoholic fatty liver disease.
Keywords: 3T3-L1 cells; Autophagy; Endoplasmic reticulum stress; Fibrosis; LX-2 cells.
Similar articles
-
Endoplasmic Reticulum Stress in Hepatic Stellate Cells Promotes Liver Fibrosis via PERK-Mediated Degradation of HNRNPA1 and Up-regulation of SMAD2.Gastroenterology. 2016 Jan;150(1):181-193.e8. doi: 10.1053/j.gastro.2015.09.039. Epub 2015 Oct 3. Gastroenterology. 2016. PMID: 26435271
-
Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.World J Gastroenterol. 2024 Apr 21;30(15):2143-2154. doi: 10.3748/wjg.v30.i15.2143. World J Gastroenterol. 2024. PMID: 38681990 Free PMC article.
-
Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.Biochem Biophys Res Commun. 2018 Jan 22;495(4):2649-2656. doi: 10.1016/j.bbrc.2017.12.143. Epub 2017 Dec 24. Biochem Biophys Res Commun. 2018. PMID: 29278707
-
Recent advancement of molecular mechanisms of liver fibrosis.J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):512-8. doi: 10.1002/jhbp.245. Epub 2015 Apr 13. J Hepatobiliary Pancreat Sci. 2015. PMID: 25869468 Free PMC article. Review.
-
Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):192-197. doi: 10.1016/j.hbpd.2018.04.003. Epub 2018 Apr 21. Hepatobiliary Pancreat Dis Int. 2018. PMID: 29709350 Review.
Cited by
-
High-Intensity Focused Ultrasound Decreases Subcutaneous Fat Tissue Thickness by Increasing Apoptosis and Autophagy.Biomolecules. 2023 Feb 18;13(2):392. doi: 10.3390/biom13020392. Biomolecules. 2023. PMID: 36830763 Free PMC article.
-
The role of autophagy in fibrosis: Mechanisms, progression and therapeutic potential (Review).Int J Mol Med. 2025 Apr;55(4):61. doi: 10.3892/ijmm.2025.5502. Epub 2025 Feb 14. Int J Mol Med. 2025. PMID: 39950330 Free PMC article. Review.
-
Endoplasmic reticulum stress-mediated cell death in liver injury.Cell Death Dis. 2022 Dec 19;13(12):1051. doi: 10.1038/s41419-022-05444-x. Cell Death Dis. 2022. PMID: 36535923 Free PMC article. Review.
References
-
- Sato T, Vargas D, Miyazaki K, Uchida K, Ariyani W, Miyazaki M, Okada J, Lizcano F, Koibuchi N, Shimokawa N (2020) EID1 suppresses lipid accumulation by inhibiting the expression of GPDH in 3T3-L1 preadipocytes. J Cell Physiol. https://doi.org/10.1002/jcp.29567 - DOI - PubMed
-
- Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A (2020) Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease. Gastroenterology. https://doi.org/10.1053/j.gastro.2019.12.054 - DOI - PubMed
-
- Bluher M (2020) Metabolically healthy obesity. Endocr Rev. https://doi.org/10.1210/endrev/bnaa004 - DOI - PubMed - PMC
-
- Cordeiro A, Costa R, Andrade N, Silva C, Canabrava N, Pena MJ, Rodrigues I, Andrade S, Ramalho A (2020) Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity? Clin Res Hepatol Gastroenterol. https://doi.org/10.1016/j.clinre.2019.10.001 - DOI - PubMed
-
- Rom O, Xu G, Guo Y, Zhu Y, Wang H, Zhang J, Fan Y, Liang W, Lu H, Liu Y, Aviram M, Liu Z, Kim S, Liu W, Wang X, Chen YE, Villacorta L (2019) Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice. EBioMedicine 41(2019):62–72. https://doi.org/10.1016/j.ebiom.2019.02.019 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical